David Sowden1. Thomas Hadwen2
- Department of Infectious Diseases, Sunshine Coast University Hospital, Queensland.
- Department of Endocrinology, Sunshine Coast University Hospital, Queensland.
Last reviewed: November 2019
Introduction
Age-relates co-morbidities, such as osteoporosis, become more important as the HIV population ages. Added to aging, associated co-morbidities, anti-retroviral therapy and the effect of HIV itself contribute to bone diseases in HIV. This review will examine bone disease in HIV populations including osteoporosis, osteonecrosis, osteomalacia followed by a discussion of bone disease in those receiving PrEP and bone disease in children.